Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (31-40 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinomaYasushi Yatabe, Keitaro Matsuo, Tetsuya Mitsudomi
Translational Lung Cancer Research|December 21, 2019
Brain metastases in oncogene-driven non-small cell lung cancerMakoto Nishino, Kenzo Soejima, Tetsuya Mitsudomi
Nature Reviews. Clinical Oncology|February 27, 2013
Surgery for NSCLC in the era of personalized medicineTetsuya Mitsudomi, Kenichi Suda, Yasushi Yatabe
Translational Cancer Research|February 4, 2022
Surgical therapy for pulmonary metastasis of breast cancerJunichi Soh, Yoshifumi Komoike, Tetsuya Mitsudomi
Oncogene|March 30, 2004
Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylationYasushi Yatabe, Tetsuya Mitsudomi, Takashi Takahashi
Cancer Research|April 3, 2008
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancerYasushi Yatabe, Takashi Takahashi, Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[Molecular targeted therapy--non-small-cell lung cancer and gefitinib]Junichi Shimizu, Yoshitsugu Horio, Tetsuya Mitsudomi
Lung Cancer (Amsterdam, Netherlands)|July 24, 2024
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?Yuko Oya, Kazuyoshi Imaizumi, Tetsuya Mitsudomi
The American Journal of Surgical Pathology|May 23, 2002
TTF-1 expression in pulmonary adenocarcinomasYasushi Yatabe, Tetsuya Mitsudomi, Takashi Takahashi
Cancer Science|January 8, 2022
Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancerTakamasa Koga, Kenichi Suda, Tetsuya Mitsudomi
Pageof 34

Showing results (31-40 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinomaYasushi Yatabe, Keitaro Matsuo, Tetsuya Mitsudomi
Translational Lung Cancer Research|December 21, 2019
Brain metastases in oncogene-driven non-small cell lung cancerMakoto Nishino, Kenzo Soejima, Tetsuya Mitsudomi
Nature Reviews. Clinical Oncology|February 27, 2013
Surgery for NSCLC in the era of personalized medicineTetsuya Mitsudomi, Kenichi Suda, Yasushi Yatabe
Translational Cancer Research|February 4, 2022
Surgical therapy for pulmonary metastasis of breast cancerJunichi Soh, Yoshifumi Komoike, Tetsuya Mitsudomi
Oncogene|March 30, 2004
Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylationYasushi Yatabe, Tetsuya Mitsudomi, Takashi Takahashi
Cancer Research|April 3, 2008
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancerYasushi Yatabe, Takashi Takahashi, Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[Molecular targeted therapy--non-small-cell lung cancer and gefitinib]Junichi Shimizu, Yoshitsugu Horio, Tetsuya Mitsudomi
Lung Cancer (Amsterdam, Netherlands)|July 24, 2024
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?Yuko Oya, Kazuyoshi Imaizumi, Tetsuya Mitsudomi
The American Journal of Surgical Pathology|May 23, 2002
TTF-1 expression in pulmonary adenocarcinomasYasushi Yatabe, Tetsuya Mitsudomi, Takashi Takahashi
Cancer Science|January 8, 2022
Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancerTakamasa Koga, Kenichi Suda, Tetsuya Mitsudomi
Pageof 34